Through a combination of bioinformatics analysis and examination of clinical tissue samples, it was determined that AIM2 expression levels were notably lower in tumor tissue samples from CRC patients compared to those from healthy individuals32. The gene discussed is AIM2; the disease is colorectal carcinoma.